From discovery through manufacturing to pharmacovigilance, DVAI agents take on the document-heavy, administrative load across the pharmaceutical value chain — structuring literature, supporting protocol design, assisting GxP batch-record and SOP work, and mapping audit-readiness. Powered by Bridge, they run on-premise, so proprietary research, genomic and manufacturing data never leaves the environment. Every regulated agent operates strictly within its regulatory boundary.
Scope & regulatory position. DVAI Pharma Agents are administrative and information-handling tools. They are not medical devices and give no clinical, diagnostic or medical advice. Within GxP environments they operate under a strict boundary — they surface, structure and flag information for a qualified human, and never create, alter, approve or sign a regulated record. Every regulated decision, and the integrity of every record, remains with the responsible person under 21 CFR Part 11 / EudraLex Annex 11.
Each cluster opens a focused set of use cases — the pain point, its impact on your organisation and the people you serve, how a voice agent addresses it, and the evidence behind it.
The pre-market end — structuring biomedical literature for discovery teams, flagging avoidable weaknesses in trial-protocol design, and speeding site feasibility — all working with non-regulated research data or anonymised metadata, never patient PII.
The regulated production floor — batch-record review, instant SOP access, and tech-transfer parameter monitoring. Every agent here operates under a strict GxP boundary: it surfaces and flags, but never signs, approves or changes a regulated record.
Post-market safety and sensitive data — structuring adverse-event intake for safety officers, and orchestrating genomic pipelines locally so multi-gigabyte datasets stay within their jurisdiction of origin.
The submission and inspection edge — drafting IMPD modules for human review and mapping cross-system traceability ahead of an MHRA inspection. Read-only, human-signed, audit-trail-safe by design.
The commercial and medical-affairs edge — field-force prep against compressing HCP access, MSL insight capture, pre-MLR compliance triage, market-access dossier synthesis, and non-clinical patient-support tracking. Every agent operates under the ABPI/EFPIA/FDA promotional firewall: it never generates promotional copy autonomously, makes off-label claims, or gives clinical advice.
Not sure where to start? Request a confidential discussion.
Get startedNo. DVAI Pharma Agents are administrative and information-handling tools. They are not medical devices and give no clinical, diagnostic or medical advice. They surface, structure and flag information for a qualified human to act on. Where a use case touches a regulated process, the agent operates strictly within that boundary.
No — and this is absolute by design. Within a GxP environment the agent does not create, alter, delete, approve or sign any regulated record. It triages and summarises for the review and validated signature of a responsible, qualified and accredited medical professional, consistent with 21 CFR Part 11 and EudraLex Annex 11. The integrity of every regulated record, and every regulated decision, stays with that responsible professional.
By keeping the agent on the administrative side of the regulatory line and the qualified professional on the decision side. It helps with the document-heavy, repetitive work — structuring literature, drafting IMPD modules for human review, mapping traceability ahead of an inspection — while every regulated judgement remains with your qualified staff. Compliance responsibility rests with you and your quality function; the agent supports that, it does not substitute for it.
No. Pharma Agents are built to run on-premise via Bridge, so sensitive research, genomic and manufacturing data stays inside your own infrastructure, according to your existing design and data-handling structures. DVAI adds to, and does not replace, the controls you already have in place.
No. In adverse-event work the agent performs administrative intake only — capturing and structuring reports into standard formats — and passes every case to a qualified Safety Officer. It makes no seriousness or causality determination; that clinical judgement is entirely human.
Through a confidential discussion and a tightly scoped pilot in your own environment, beginning with a non-safety-critical, administrative use case. Deep Voice AI is pre-revenue, so we would agree success measures on your own operation rather than pointing to results we have not yet earned.
Explore pharma agents use cases for your organisation. Request a confidential, no-obligation discussion to scope a pilot.
Every enquiry is held in confidence. We’ll walk you through the use cases relevant to you and scope how a sovereign deployment would work in your environment — with no obligation to proceed.
Statistics describe demand and conditions across the relevant sector and are drawn from the cited public sources. They characterise the sector-level problem these agents address; they are not performance claims for any DVAI product. Deep Voice AI Limited is a pre-revenue company and makes no representation as to outcomes for any individual organisation. Figures are current as at the date of the cited publications.
Capable AI, on your terms — not the cloud’s.